Human Pluripotent Stem Cells to Produce Cell-based Cancer Immunotherapy.

about

Human Pluripotent Stem Cells to Produce Cell-based Cancer Immunotherapy.

Item

http://www.wikidata.org/entity/Q46350666

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Human Pluripotent Stem Cells to Produce Cell-based Cancer Immunotherapy.

@en

Human Pluripotent Stem Cells to Produce Cell-based Cancer Immunotherapy.

@nl

type

Item

label

Human Pluripotent Stem Cells to Produce Cell-based Cancer Immunotherapy.

@en

Human Pluripotent Stem Cells to Produce Cell-based Cancer Immunotherapy.

@nl

prefLabel

Human Pluripotent Stem Cells to Produce Cell-based Cancer Immunotherapy.

@en

Human Pluripotent Stem Cells to Produce Cell-based Cancer Immunotherapy.

@nl

P1476

Concise Review: Human Pluripotent Stem Cells to Produce Cell-Based Cancer Immunotherapy

@en

P2093

Huang Zhu

http://www.w3.org/2001/XMLSchema#string

Robert H Blum

http://www.w3.org/2001/XMLSchema#string

Yi-Shin Lai

http://www.w3.org/2001/XMLSchema#string

P2860

Natural Killer Cells for Immunotherapy - Advantages of the NK-92 Cell Line over Blood NK Cells

NKT cell subsets as key participants in liver physiology and pathology

Natural Killer Cell-Based Therapies Targeting Cancer: Possible Strategies to Gain and Sustain Anti-Tumor Activity

NK Cell-Mediated Antibody-Dependent Cellular Cytotoxicity in Cancer Immunotherapy

An overview of the intrathymic intricacies of T cell development

Membrane-bound IL-21 promotes sustained ex vivo proliferation of human natural killer cells

Natural killer cells generated from cord blood hematopoietic progenitor cells efficiently target bone marrow-residing human leukemia cells in NOD/SCID/IL2Rg(null) mice

CD16 is indispensable for antibody-dependent cellular cytotoxicity by human monocytes

TET2 mutations in acute myeloid leukemia (AML): results from a comprehensive genetic and clinical analysis of the AML study group.

Induced pluripotent stem cell lines derived from human somatic cells

P304

134-145

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1002/STEM.2754

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Dan S Kaufman

Ye Li

P577

2018-01-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29235195

http://www.w3.org/2001/XMLSchema#string

P921

immunotherapy

P932

5914526

http://www.w3.org/2001/XMLSchema#string